Outset Medical Inc Aktie News

NEWTOWN, Pa. , Nov. 28, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Outset Medical, Inc. (NASDAQ: OM), resulting from allegations of providing potentially misleading business information to the investing public.

Outset Medical, Inc. ( OM ) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Company Participants James Mazzola - Vice President of Corporate Communications & Investor Relations Leslie Trigg - President, CEO & Chairman Renee Gaeta - CFO, Principal Financial Officer & Principal Accounting Officer Conference Call Participants Frederick Wise - Stifel, Nicolaus & Company, Incorporated, Research ...

SAN JOSE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the third quarter ended September 30, 2025 and revised its 2025 revenue guidance.

Data from over 1 Million Tablo Treatments Among the Findings Presented at the American Society of Nephrology's Kidney Week 2025 Data from over 1 Million Tablo Treatments Among the Findings Presented at the American Society of Nephrology's Kidney Week 2025

SAN JOSE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 2025 Stifel Healthcare conference on Wednesday, November 12, 2025, at 10:40 a.m.

SAN JOSE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter 2025 after the close of trading on Monday, November 10, 2025.

Outset Medical, Inc. (NASDAQ:OM ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 7:00 AM EDT Company Participants Leslie Trigg - President, CEO & Chairman Renee Gaeta - CFO, Principal Financial Officer & Principal Accounting Officer Conference Call Participants Steven Trainor Presentation Steven Trainor Good morning, everyone. I'm Steven Trainor, Vice President with ...

Outset Medical allegedly misled investors on Tablo's FDA status, sales risks, and growth prospects, lacking a reasonable basis for its positive outlook.